未登录

B

Bingye Zhu

Shanghai University

H指数:11

被引数:284

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing

FOXM1可能通过单细胞和bulk RNA测序作为桥接因子，介导透明细胞肾细胞癌的预后与免疫关系。

DISCOVER ONCOLOGY

IF2.9

2025-04-280

OA

Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma

通过单细胞和批量测序分析YBX1在肝肝细胞癌的预后价值和免疫特性中的作用

JOURNAL OF GENE MEDICINE

IF2.2

2024-03-062

PRE

Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC

GENES AND IMMUNITY

IF4.5

2023-07-105

PRE

Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity

PTTG1升高可预测肾脏肾透明细胞癌的不良预后并与免疫力相关

IF3.6

2023-02-012

OAAI

A novel 17 apoptosis-related genes signature could predict overall survival for bladder cancer and its associations with immune infiltration

IF3.6

2022-11-017

OAAI

Elevated THBS3 predicts poor overall survival for clear cell renal cell carcinoma and identifies LncRNA/RBP/THBS3 mRNA networks

升高的THBS3预测透明细胞肾细胞癌的总体生存率较差，并确定LncRNA/RBP/THBS3 mRNA网络

IF3.4

2022-08-314

OA

Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction

IF3.4

2022-08-2418

PRE

Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms

生存预后，肿瘤免疫景观和ADAMTS14在透明细胞肾细胞癌中的免疫反应及其潜在机制

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-2915

OAAI

A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2021-03-0416

OAAI

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

CANCER CELL INTERNATIONAL

IF6

2021-01-1126

OAAI